
AIMBio-Mat: An AI-Native FAIR Platform for Closed-Loop Materials Discovery and Biomedical Translation
AIMBio proposes a governance-aware framework that treats materials discovery as a constrained optimization problem solvable by uncertainty-quantified ML and active learning. The work addresses a structural gap in biomedical AI: existing materials and biomedical datasets remain siloed, blocking end-to-end reasoning across composition, manufacturing, safety, and regulatory constraints. By coupling knowledge graphs with human-in-the-loop workflows and risk-tiered governance, the framework aims to accelerate closed-loop discovery cycles where models propose candidates, humans validate, and feedback loops refine predictions. This matters because biomedical materials remain a bottleneck in drug delivery and implant development, and the framework's emphasis on FAIR metadata and model documentation signals growing industry demand for reproducibility and regulatory transparency in AI-driven R&D.58



















